Journal of Clinical Microbiology Studies Demonstrate Two Investigational Diagnostics Outperform Current Tests in Detecting Early Lyme Disease

The CDC’s standard two-tier Lyme diagnostic misses the majority of early cases, delaying treatment and increasing the risk of developing persistent, debilitating symptoms for patients. The two novel ...
FiercePharma

Fujifilm Biotechnologies cuts ribbon on $3.2B antibody facility in NC

Excitement around Fujifilm Biotechnologies’ massive new cell culture facility in Holly Springs, North Carolina, has been growing steadily since 2021, prompting a beefed-up investment from the company ...
Yahoo Finance

SystImmune, Inc. to Present New Clinical Data on Izalontamab Brengitecan and BL-M07D1 Highlighting Strength of Differentiated Antibody Drug Conjugate (ADC) Platform

REDMOND, Wash., Sept. 24, 2025 /PRNewswire/ -- SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced the presentation of data on iza-bren (izalontamab brengitecan) and ...
Yahoo Finance

Moderna's COVID-19 Vaccine Update Boosts Antibodies 16-Fold, Data Shows

Moderna Inc. (NASDAQ:MRNA) on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of mNEXSPIKE (COVID-19 Vaccine, mRNA), which targets the LP.8.1 variant of SARS-CoV-2. The data ...
PharmiWeb

Biomunex announces investment from new shareholders to accelerate its growth and development of its portfolio of innovative bispecific antibodies for cancer immunotherapy

New shareholders, including private investors and family offices, are investing alongside long-standing shareholders who have been supportive since company's inception. This capital increase is fully ...